Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | 13 | 1 | 2 | 0 | €63.99 | €83.21 | 30.028% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €3.00 | €4.00 | 33.333% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €39.80 | €50.00 | 25.628% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.40 | €24.97 | 6.723% |
| QIAGEN NV | 9 | 0 | 1 | 0 | €40.47 | €47.84 | 18.212% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €85.20 | €100.00 | 17.371% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €38.20 | €35.00 | -8.377% |
| Geron Corp. | 17 | 0 | 0 | 0 | €4.15 | €5.57 | 34.363% |
| Xencor Inc. | 14 | 1 | 3 | 0 | €17.80 | €31.70 | 78.070% |
| Charles River Labs Intl | 11 | 0 | 0 | 0 | €194.10 | €249.59 | 28.589% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.09 | €26.01 | 29.449% |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €24.00 | €28.29 | 17.878% |
| Corcept Therapeutics Inc. | 14 | 0 | 1 | 0 | €26.23 | €36.87 | 40.557% |
| Neurocrine Bioscience | 32 | 0 | 0 | 0 | €125.20 | €140.87 | 12.514% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €21.00 | €45.21 | 115.286% |
| X4 Pharmaceuticals, Inc. | 6 | 0 | 0 | 0 | €1.02 | €3.69 | 261.301% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.76 | €8.35 | 374.321% |
| Lexicon Pharmaceuticals Inc. | 3 | 0 | 1 | 0 | €1.63 | €6.00 | 267.647% |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Insmed Inc. | 32 | 1 | 2 | 0 | €60.50 | €64.52 | 6.643% |
| Rigel Pharmaceutical Inc. | 12 | 0 | 1 | 0 | €0.84 | €13.78 | 1543.292% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 0 | 0 | €7.09 | €8.50 | 19.887% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €6.35 | €10.00 | 57.480% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €51.24 | €55.00 | 7.338% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €16.20 | €45.10 | 178.364% |